Repopulation of blood lymphocyte sub-populations in rheumatoid arthritis patients treated with the depleting humanized monoclonal antibody, CAMPATH-1H

Immunology

Volumn 88, Issue 1, 1996, Pages 13-19

  Brett, S ^a   Baxter, G ^b   Cooper, H ^b   Johnston, J M ^b   Tite, J ^b   Rapson, N ^b  

^a GLAXOSMITHKLINE   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; CD14 ANTIGEN; CD16 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; HLA DR ANTIGEN; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; CD52 ANTIGEN; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; TUMOR ANTIGEN;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTE SUBPOPULATION; MONOCYTE; NATURAL KILLER CELL; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHENOTYPE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; T LYMPHOCYTE; B LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; IMMUNOLOGY; LEUKOCYTE COUNT; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MULTICENTER STUDY; PHYSIOLOGY; TIME;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD45; ANTIGENS, NEOPLASM; ARTHRITIS, RHEUMATOID; B-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; GLYCOPROTEINS; HLA-DR ANTIGENS; HUMANS; KILLER CELLS, NATURAL; LEUKOCYTE COUNT; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; MONOCYTES; TIME FACTORS;

EID: 0029666221     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1996.d01-650.x     Document Type: Article

References (27)

1. RIECHMANN I., CLARK M.R., WALDMANN H. & WINTER G. (1988) Reshaping human antibodies for therapy. Nature 332, 323.
2. CROWE J.S., HALL V., SMITH M.A., COOPER H.J. & TITE J.P. (1992) Humanised monoclonal antibody CAMPATH-1H; myeloma cell expression of cDNA constructs and comparison of effector mechanisms of myeloma and chinese hamster ovary derived material. Clin Exp Immunol 87, 105.
3. ISAACS J.D., WATTS R.A., BAZELMAN B.L. et al. (1992) Humanised monoclonal antibody therapy for rheumatoid arthritis. Lancet 340, 748.
4. DYER M.J.S., HALE G., MARCUS R. & WALDMANN H. (1990) Remission induction in patients with lymphoid malignancies using unconjugated CAMPATH-1H monoclonal antibodies. Leukemia and Lymphoma 2, 179.
5. HALE G., XIA M.-Q., TIGHE H.P., DYER M.J.S. & WALDMANN H. (1990) The CAMPATH-1H antigen (CDw52). Tissue Antigens 35, 118.
6. XIA M.-Q., TONE M., PACKMAN L., HALE G. & WALDMANN H. (1991) Characterisation of the CAMPATH-1H (CDw52) antigen: biochemical analysis and cDNA cloning reveal an unusually small peptide backbone. Eur J Immunol 21, 1677.
7. XIA M.-Q., HALE G., LIFELY M.R. et al. (1993) Structure of the CAMPATH-1H, aglycosyl-phosphatidylinositol anchored glycoprotein which is an exceptionally good target for complement lysis. Biochem J 293, 633.
8. HALE G. & WALDMANN H. (1994) CAMPATH-1H monoclonal antibodies in bone marrow transplantation. J Hematotherapy 3, 15.
9. ROWAN W.C., HALE G., TITE J.P. & BRETT S.J. (1995) Cross-linking of the CAMPATH-1 antigen (CD52) triggers activation of normal human T lymphocytes. Int Immunol 7, 69.
10. BRAHN E., HELFGOTT S.M., BELLI J.A. et al. (1984) Total lymphoid irradiation therapy in refractory arthritis. Arthritis Rheum 27, 48.
11. PAULUS H.E., MACHLEDER H.I., LEVINE S., YU D.I. & MACDONALD N.S. (1977) Lymphoid involvement in rheumatoid arthritis. Studies during thoracic duct drainage. Arthritis Rheum 20, 1249.
12. MCCURIE W.J. & BAYLIS G.E. (1991) Immunosuppressive therapy for rheumatic disease. Curr Opin Rheum 3, 355.
13. STASTRY P. (1978) Association of the B cell alloantigen DRw4 with rheumatoid arthritis. New Engl J Med 298, 869.
14. WATTS R.A. & ISAACS J.D. (1992) Immunotherapy of rheumatoid arthritis. Ann Rheumatol 51, 577.
15. REITHMULLER G., RIEBER E.P., KIEFERSAUER S. et al. (1992) From anti-lymphocyte serum to therapeutic monoclonal antibodies: First experiences with a chimeric CD4 antibody in the treatment of autoimmune disease. Immunol Rev 129, 81.
16. WEINBLATT M.E., JOHNSTON J.M., HAZLEMAN B.L. & MANNA V.K. (1992) Treatment of rheumatoiod arthritis (RA) with a single dose influsion of CAMPATH-1H. Arthritis Rheum 35, S105.
17. ISAACS J.D., MANNA V.K., RAPSON N. et al. CAMPATH-1H in rheumatoid arthritis - an IV dose ranging study. (In press).
18. AKBAR A.N., SALMON M. & JANOSSY G. (1991) The synergy between naive and memory T cells during activation. Immunol Today 12, 184.
19. BEVERLEY P.C.L. (1992) Functional analysis of human T cell subsets defined by CD45 isoform expression. Seminars in Immunology 4, 35.
20. FREITAS A.A. & ROCHA B.B. (1992) Lymphocyte lifespans: hommeostais, selection and competition. Immunol Today 14, 25.
21. WEINBERG K. & PARKMAN R. (1995) Age, the thymus and T lymphocytes. New Engl J Med 332, 182.
22. MACKALL C.L., FLEISHER T.A., BROWN M.R. et al. (1995) Age, thymopoiesis, and CD4+ T lymphocyte regeneration after intensive chemotherapy. New Engl J Med 332, 143.
23. RUDERMAN E.M., WEINBLATT M.E., THURMOND L.M., PINKUS G.S. & GRAVALLESE E.M. (1995) Synovial tissue response to treatment with CAMPATH-1H. Arthritis Rheum 38, 254.
24. MOREAU T., THORPE J., MILLER D. et al. (1994) Preliminary evidence from gadolinium enhanced magnetic resonance imaging for reduction in disease activity following lymphocyte depletion in patients with multiple sclerosis. Lancet 344, 298.
25. DOHERTY P.C. (1993) Immune exhaustion - driving virus specific CD8+ T cell to death. Trends Microbiol 1, 207.
26. AKBAR A.N., BORTHWICK N., SALMON M. et al. (1993) The significance of low bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections. The role of apoptosis in T cell memory. J Exp Med 178, 427.
27. SALMON M., PILLING D., BORTHWICK N. et al. (1994) The progressive differentiation of primed T cells is associated with increasing susceptibility to apoptosis. Eur J Immunol 24, 892.